Method of treating vitiligo with interferon-gamma antibody
AssigneeElixiron Immunotherapeutics (Hong Kong) Limited
InventorsHung-Kai Chen, Pei-Han Chung, Cheng-Lun KU, Chau Yee Ng
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for treating vitiligo using antibodies which specifically bind to IFN-γ.
Claims35
A method for treating vitiligo, comprising administering to a subject in need thereof a composition comprising a therapeutically effective amount of an IFN-γ antibody and a pharmaceutically acceptable carrier.
(canceled)
(canceled)
The method of claim 17, wherein an infection or a drug induced adverse effect was not induced by 2A6Q in an in vivo toxicology assay.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A composition comprising a therapeutically effective amount of an IFN-γ antibody and a pharmaceutically acceptable carrier for use in treating vitiligo in a subject in need thereof.
Dependencies are inferred from the claim text.